IVI and Fiji
Typhoid in Fiji – Vaccination & Elimination (TY-FIVE) consortium:
A new partnership between IVI, the Fijian Ministry of Health, the Peter Doherty Institute for Infection and Immunity (University of Melbourne), and the Murdoch Children’s Research Institute, TY-FIVE will conduct a pilot vaccine introduction of Bharat Biotech’s Typbar-TCV by vaccinating the entire population of the island of Vanua Levu (population around 132,000) to try to eliminate typhoid from the Northern Island of Fiji and strengthen Fiji’s current symptomatic typhoid surveillance system.
Fiji is a non-member state of the International Vaccine Institute (IVI).
To read about IVI’s member state benefits package, click here.